Post

Oncternal sells assets for up to $68m and calls it quits

American oncology company Oncternal Therapeutics is to wind down operations after announcing the sale of its main drug programmes. Delaware-based Ho’ola …
Sanofi’s riliprubart gains ODD status from Japan’s MHLW for CIDP

Sanofi's antibody riliprubart has received orphan drug designation (ODD) from Japan's Ministry of Health, Labour and Welfare (MHLW) for its …
EU’s Pharma Package falls short of Europe’s goal of global competitiveness

In a bid to chase competitiveness, the EU is advancing its most drastic revision of pharmaceutical law in 20 years. …
AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline

AbbVie has agreed to acquire Capstan Therapeutics for up to $2.1bn, adding a “high-risk, high-reward” clinical-stage in vivo CAR-T candidate …
Piramal Pharma announces $90m investment to expand US sites

Piramal Pharma Solutions has announced an investment of $90m to expand its two US facilities, enhancing manufacturing capabilities for sterile …

FDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiency

The US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC [immune globulin infusion …
WHO accuses China of withholding Covid-19 genetic data

The World Health Organization (WHO) says it is unable to concretely identify the origins of the virus that led to …
US trade tariffs and the potential impact on pharma supply chains

When Donald Trump was elected the 47th president of the United States of America, the outlook for pharmaceuticals was unclear, …
Vetter breaks ground on $285m US clinical manufacturing site

German contract development and manufacturing organisation Vetter Pharma has commenced construction of a new $285m clinical manufacturing facility in Des …
CKD anemia market expected to reach $5.3bn across the 7MM by 2034

The chronic kidney disease (CKD) anemia market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the …
FDA removes safety programme for CAR-T therapies to boost uptake

The US Food and Drug Administration (FDA) has removed the risk evaluation and mitigation strategies (REMS) requirements for all approved …
Sobi gains FDA approval for Gamifant to treat HLH/MAS

The US Food and Drug Administration (FDA) has approved Sobi's Gamifant (emapalumab) to treat adults and children with haemophagocytic lymphohistiocytosis …
Torrent Pharmaceuticals to acquire stake in JB Pharma for $3bn

Torrent Pharmaceuticals, headquartered in Gujerat, India, has signed definitive agreements for the acquisition of a controlling stake in JB Chemicals …
FDA approves label updates for BMS’ CAR T cell therapies

Bristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has given approval to label updates …
AI in drug discovery: from hypothetical to reality

AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to revolutionise how …